AMP has been in the wars in recent years. Its plan to divest its life insurance arm has faced various obstacles, including opposition from some of its major institutional shareholders as well as New Zealand regulators. It has also scrapped its 2019 interim dividend, a course of action typically taken only by companies suffering balance sheet challenges. In recent years, when one of a company’s existing hybrids approaches its first...